Who runs GLPTree and why it exists

My name is Rolando Valenzuela. I am a web developer and independent publisher based in Port Saint Lucie, Florida. I am not a physician, pharmacist, nurse, or any kind of licensed healthcare professional. I have no clinical training and I do not practice medicine in any form.

I built GLPTree because I spent time trying to understand GLP-1 medications — for myself, for people I know — and found that nearly every source was either buried in jargon, shaped by a brand relationship, or trying to sell something. The actual FDA prescribing information, peer-reviewed trial data, and published clinical results exist; they just are not presented in a way that a non-clinician can readily use.

My background is in web development and entrepreneurship. I know how to read a clinical trial, cross-reference a prescribing label, and build tools that make complex data approachable. I do not know how any particular medication will work for any particular person — that is what physicians are for.

GLP-1 receptor agonists have become one of the most-prescribed drug classes in US history. Millions of people are starting, switching, or discontinuing these medications every year, and most of them are doing so with limited access to clear information about what the trials actually showed, what the dosing schedules actually look like, what the side-effect profiles actually are, and what the realistic cost options are.

The information vacuum is filled — badly — by pharma marketing, affiliate-incentivized blogs, and social media speculation. GLPTree is an attempt to offer something different: sourced, educational content that treats readers as adults who are capable of understanding clinical data and using it in a conversation with their doctor.

GLPTree does not tell anyone what medication to take. It explains what the evidence says, who the evidence applies to, and what questions a person might bring to their healthcare provider. The decision to start, change, or stop any medication belongs to the patient and their clinician — not to a website.

GLPTree is:

• An educational resource about GLP-1 receptor agonists, metabolic medications, and related clinical research.
• A publisher of free calculators that apply publicly available clinical-trial data and established nutritional formulas to individual inputs.
• An independent site with no affiliation to any pharmaceutical manufacturer, telehealth company, compounding pharmacy, or healthcare provider.
• A site funded by display advertising. Ads are served by Google AdSense. Ad content is determined by Google's advertising network and has no influence on editorial decisions.

GLPTree is not:

• A medical practice, clinic, or telehealth service.
• A source of personalized medical advice, diagnosis, or treatment recommendations.
• Affiliated with Novo Nordisk, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Pfizer, or any other pharmaceutical or biotech company.
• A participant in affiliate programs for medications, compounded GLP-1 products, or telehealth services. We do not earn commissions from medication purchases or prescriptions.
• A substitute for a licensed clinician. No content on this site replaces the judgment of your physician or healthcare team.

GLPTree is funded entirely through display advertising. Ads are served by Google AdSense. We do not accept paid placements, sponsored posts, branded content, or native advertising of any kind. We do not participate in affiliate programs for medications, telehealth services, or compounding pharmacies.

Ads displayed on GLPTree are selected by Google's advertising system based on page content, your browsing history, and other factors determined by Google. The presence of any advertisement on this site does not constitute an endorsement of that product or service by GLPTree. Ad revenue does not influence what we write, which medications we cover, or how we present clinical data.

We may in the future accept sponsorships from non-pharmaceutical companies (for example, fitness technology or nutrition companies) provided those relationships are disclosed prominently on every page where sponsored content appears. As of the date of this page's last review, no such sponsorships exist.

All editorial decisions — what topics to cover, how claims are framed, which sources are cited, when content is updated — are made independently by the publisher. No advertiser, pharmaceutical company, or third party has any input into editorial content. If a factual error is identified, we correct it and log the correction on the affected page with a date. If new clinical data changes what a page says, we update the page and update the last-reviewed date.

GLPTree uses AI-assisted drafting tools to accelerate research and writing. All medical claims are human-verified against primary sources — FDA prescribing information, published peer-reviewed trials, ClinicalTrials.gov entries, and official manufacturer press releases for trial data — before any content is published. Where AI tools contributed to a draft, a human review against primary sources is mandatory before publication. See our Editorial Policy for the full sourcing and verification process.

For corrections, press inquiries, partnership questions, or general feedback, email [email protected]. Please do not email health or medical questions — we cannot provide medical advice and will not attempt to do so. See our full Contact page for details on what to expect.